Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow Jrheum on BlueSky
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
Research ArticleAccepted Article

The risk of cardiovascular events associated with disease-modifying antirheumatic drugs in rheumatoid arthritis

Gulsen Ozen, Sofia Pedro and Kaleb Michaud
The Journal of Rheumatology August 2020, jrheum.200265; DOI: https://doi.org/10.3899/jrheum.200265
Gulsen Ozen
From the University of Nebraska Medical Center, Omaha, NE; FORWARD, The National Databank for Rheumatic Diseases, Wichita, KS. Partial funding for this study came from Pfizer through the ASPIRE competitive grant program – no one from Pfizer had input on the final manuscript. Dr. Michaud received additional research grant funding from the Rheumatology Research Foundation. Address correspondence to Kaleb Michaud, 986270 Nebraska Medical Center, Omaha, NE 68198. kmichaud@unmc.edu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sofia Pedro
From the University of Nebraska Medical Center, Omaha, NE; FORWARD, The National Databank for Rheumatic Diseases, Wichita, KS. Partial funding for this study came from Pfizer through the ASPIRE competitive grant program – no one from Pfizer had input on the final manuscript. Dr. Michaud received additional research grant funding from the Rheumatology Research Foundation. Address correspondence to Kaleb Michaud, 986270 Nebraska Medical Center, Omaha, NE 68198. kmichaud@unmc.edu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kaleb Michaud
From the University of Nebraska Medical Center, Omaha, NE; FORWARD, The National Databank for Rheumatic Diseases, Wichita, KS. Partial funding for this study came from Pfizer through the ASPIRE competitive grant program – no one from Pfizer had input on the final manuscript. Dr. Michaud received additional research grant funding from the Rheumatology Research Foundation. Address correspondence to Kaleb Michaud, 986270 Nebraska Medical Center, Omaha, NE 68198. kmichaud@unmc.edu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • References
  • PDF
Next
Loading

Article Information

jrheum.200265
DOI 
https://doi.org/10.3899/jrheum.200265
PubMed 
32801134

Published By 
The Journal of Rheumatology
Print ISSN 
0315-162X
Online ISSN 
1499-2752
History 
  • Published online August 15, 2020.

Article Versions

  • You are currently viewing a Latest version of this article (August 15, 2020 - 04:00).
  • latest version (October 15, 2020 - 04:00).
  • View the most recent version of this article
Copyright & Usage 
© 2020 The Journal of Rheumatology

Author Information

  1. Gulsen Ozen,
  2. Sofia Pedro and
  3. Kaleb Michaud
  1. From the University of Nebraska Medical Center, Omaha, NE; FORWARD, The National Databank for Rheumatic Diseases, Wichita, KS.
    Partial funding for this study came from Pfizer through the ASPIRE competitive grant program – no one from Pfizer had input on the final manuscript. Dr. Michaud received additional research grant funding from the Rheumatology Research Foundation.
    Address correspondence to Kaleb Michaud, 986270 Nebraska Medical Center, Omaha, NE 68198. kmichaud@unmc.edu

Article usage

Article usage: August 2020 to April 2025

AbstractFullPdf
Aug 202019390153
Sep 2020475037
Oct 2020302027
Nov 2020232011
Dec 2020198015
Jan 2021273014
Feb 2021234012
Mar 2021240022
Apr 2021171613
May 2021221614079
Jun 20217374822
Jul 20216372016
Aug 20215681817
Sep 20212572526
Oct 20212312735
Nov 20212691922
Dec 20212551819
Jan 20222444031
Feb 20221442013
Mar 20223202745
Apr 20222602225
May 20226012697
Jun 2022438158
Jul 2022407354
Aug 20225011061
Sep 2022588043
Oct 2022569973
Nov 2022567744
Dec 2022192831
Jan 20233211959
Feb 2023427541
Mar 2023395840
Apr 2023284325
May 2023416953
Jun 2023245730
Jul 2023329658
Aug 2023305643
Sep 2023229936
Oct 20233612745
Nov 2023426741
Dec 2023287338
Jan 2024355929
Feb 2024528853
Mar 2024186138
Apr 2024286142
May 2024306654
Jun 2024294032
Jul 2024346350
Aug 2024324623
Sep 2024514741
Oct 2024745533
Nov 2024585930
Dec 2024695142
Jan 2025545034
Feb 2025436420
Mar 2025437024
Apr 2025574643

Statistics from Altmetric.com

Next
Back to top

In this issue

The Journal of Rheumatology
Vol. 52, Issue 6
1 Jun 2025
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The risk of cardiovascular events associated with disease-modifying antirheumatic drugs in rheumatoid arthritis
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Accepted manuscript
The risk of cardiovascular events associated with disease-modifying antirheumatic drugs in rheumatoid arthritis
Gulsen Ozen, Sofia Pedro, Kaleb Michaud
The Journal of Rheumatology Aug 2020, jrheum.200265; DOI: 10.3899/jrheum.200265

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Accepted manuscript
The risk of cardiovascular events associated with disease-modifying antirheumatic drugs in rheumatoid arthritis
Gulsen Ozen, Sofia Pedro, Kaleb Michaud
The Journal of Rheumatology Aug 2020, jrheum.200265; DOI: 10.3899/jrheum.200265
del.icio.us logo Twitter logo Facebook logo  logo Mendeley logo
  • Tweet Widget
  •  logo
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • References
  • PDF

Related Articles

Cited By...

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2025 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire